X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Comm & Energy
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Election 2016
    • Polling Explorer
    • Just In
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
    • Oddly Enough
    • Faithworld
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Reused pacemakers safe option in poor nations
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Health News | Wed Oct 26, 2011 1:57pm EDT

Reused pacemakers safe option in poor nations

By Amy Norton | NEW YORK

NEW YORK (Reuters Health) - Recycled pacemakers donated from U.S. funeral homes could offer a safe way to get the heart devices to poor people in the developing world, a small study suggests.

It's been estimated that between 1 million and 2 million people worldwide die each year because they have no access to a pacemaker -- an implanted device that uses electrical pulses to the heart to maintain a normal heartbeat.

Pacemakers are used to treat certain long-term arrhythmias, disturbances in the heart's rate and rhythm. Arrhythmias can trigger symptoms like fatigue, breathlessness and fainting -- or, if severe, prove fatal.

In India, where the used pacemakers ended up, the devices cost $2,200 to $6,600. That's more than many poor and middle-class Indians make in a year. And it doesn't even include doctor and hospital fees, or the cost of the wires connected to the pacemaker.

One potential, untapped source of pacemakers for the world's poor could be the significant number of Americans who die each year with a still-functioning implant.

A survey of Michigan and Illinois morticians, for example, found that 19 percent of the deceased had a pacemaker or other heart device. But the large majority of those devices are buried with the body. And if they are removed, they are usually thrown away as medical waste.

A small percentage, however, have been donated to developing nations as part of small-scale efforts by some charitable groups.

In the new study, U.S. researchers followed 53 heart patients in India who had received pacemakers donated from U.S. funeral homes.

They found that all of the patients survived the surgery and fared well immediately afterward. And there were no cases of infection or pacemaker malfunctions over an average follow-up of nearly two years.

A few patients did die over the study period, but none of the deaths was related to the pacemaker itself, the researchers report in the American Journal of Cardiology.

The new results bolster earlier data showing no increase in infections, malfunctioning or overall complications in hundreds of patients with reused pacemakers (see Reuters Health story from May 20, 2010).

Recycled pacemakers "appear safe, provided you take precautions and follow the proper protocol," said lead researcher Dr. Bharat K. Kantharia, of the University of Texas Health Science Center in Houston.

The pacemakers in this study were collected over six years from U.S. funeral homes, with permission from the families of the deceased.

Of 122 pacemakers Kantharia's team collected, half had enough battery life left (more than 3 years) to be used again. They were partially sterilized, then sent to Holy Family Hospital in Mumbai, India. There, the devices underwent final sterilization and were implanted in 53 heart patients.

A quarter of the patients lived in remote areas, and could not be followed up after successfully having the pacemaker implanted -- a limitation of implanting the devices in poor people in the developing world, according to Kantharia.

"But the ones who were followed up were doing well," he said. Of those 40 patients, all but two reported "marked improvement" in their symptoms and quality of life, according to the researchers.

And while four died over the study period, their deaths were not linked to the pacemakers.

"All we are saying is, there are people who need a pacemaker and would not otherwise get one," Kantharia said. "And maybe this will help them live a normal life."

But there are still significant barriers to getting recycled pacemakers to the world's poor on any large scale.

One is that the safety needs further study. "This study is suggestive that it's safe," said Dr. Thomas Crawford, an assistant professor of cardiovascular medicine at the University of Michigan in Ann Arbor.

"But definitive data are not available yet," said Crawford, who was not involved in the study.

Crawford and his colleagues in Michigan are working on getting pacemakers to the developing world on a wider scale. In a study dubbed Project My Heart - Your Heart, the researchers have collected more than 4,000 pacemakers from funeral homes in the past three years.

The goal is to have a supply of pacemakers that have been inspected and sterilized under a "strict protocol," and can then be sent to medical centers in the developing world that have the expertise to do the implantation. Those patients can then be followed to better pin down the safety and effectiveness of reused pacemakers.

But first, there are legal questions. In the U.S., the Food and Drug Administration (FDA) has approved pacemakers only for one-time use, meaning they cannot be recycled for U.S. patients. Pacemakers that are collected in the U.S. but sterilized overseas may not, however, fall under the FDA's jurisdiction.

The Michigan researchers are currently trying to get the FDA's OK to study their recycled pacemakers overseas as "investigational" devices.

"We want to try to prove that this is safe and efficacious," Crawford said.

Both Crawford and Kantharia said there are logistical issues as well, including getting pacemakers from the U.S. to those impoverished patients who need them.

And what happens when the battery dies is still an open question.

The Michigan researchers are working with a Detroit-based charity called World Medical Relief, which specializes in delivering used medical equipment to underdeveloped countries.

SOURCE: bit.ly/rP1nVQ American Journal of Cardiology, online October 14, 2011.

Trending Stories

    Editor's Pick

    LIVE: Election 2016

    Sponsored Topics

    Next In Health News

    Women with dense breasts may need annual mammograms

    (Reuters Health) - While most older women might not need breast cancer screening with mammography more often than every three years, some women with dense breasts may need mammograms every year, U.S. research suggests.

    Eat your food packaging, don't bin it - scientists

    ROME (Thomson Reuters Foundation) - Scientists are developing an edible form of packaging which they hope will preserve food more effectively and more sustainably than plastic film, helping to cut both food and plastic waste.

    Pfizer boosts cancer drug roster with $14 billion Medivation deal

    Pfizer Inc , beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy